Categories: News

Xojo 2025r2 Focuses on Fundamentals with Core Improvements to Increase Developer Productivity

AUSTIN, Texas, July 8, 2025 /PRNewswire/ — Xojo, Inc., the creators of Xojo—a powerful cross-platform development tool and programming language—today announced the release of Xojo 2025 Release 2. This update delivers key performance improvements and new features designed to enhance development across desktop, web and mobile platforms. Among the highlights, compiling with Aggressive Optimization now uses faster, more efficient frameworks. A new Random.UUID shared method has been added, making it easier to generate universally unique identifiers.

- Advertisement -

Platform-specific enhancements include improved XAML integration on Windows and support for direct PDF printing. Web applications benefit from updated WebStyle capabilities, which now support hover, pressed and visited states for more dynamic interfaces. On mobile, updates include multi-photo selection, biometric authentication on Android and easier file sharing.

- Advertisement -

“Xojo remains committed to supporting developers at every level in creating native applications across platforms,” said Geoff Perlman, Xojo’s Founder and CEO. “This release delivers significant performance improvements and new features that directly address the real-world needs of developers building desktop, web and mobile applications. Our goal is to provide a tool that evolves alongside their challenges and opportunities, helping them become more productive, creative and successful.”

- Advertisement -

New Features and Updates:

- Advertisement -
  • Optimized (faster, larger) frameworks are used when compiling with Aggressive Optimization
  • Updated to SQLite 3.49.2 for all platforms
  • Added Random.UUID shared method
  • Enhanced XAML integration for Windows applications
  • Added support to change the Shell.Backend on Windows to use PowerShell in addition to cmd
  • DesktopHTMLViewer now supports printing directly to a PDF file using PrintToPDF
  • Improved WebStyle supports hover, pressed and visited states
  • Added ToPicture method to Web and Mobile MapViewer control to get a map as a picture
  • Select and use multiple photos at once on iOS with MobileImagePicker
  • New Android UserAuthentication class adds facial recognition, fingerprint and passcodes
  • MobileSharingPanel allows sharing of multiple images and files more easily

About Xojo
Xojo is a cross-platform development tool for building native apps for macOS, Windows, Linux, iOS, Android, the web and Raspberry Pi. For over 25 years, Xojo has supported a growing community of developers passionate about creating powerful applications with ease. Learn more at xojo.com. Download Xojo 2025 Release 2 at xojo.com/download.

- Advertisement -

Availability
Xojo is free for learning and development, as well as for building apps for Linux and Raspberry Pi. Paid licenses start at $99 for a single-platform Desktop license and $399 for cross-platform Desktop, Mobile, or Web development. Xojo Pro and Pro Plus licenses, starting at $799, offer additional support and resources for professional developers. Special licensing is available for educators and students. Visit xojo.com/store for details. 

- Advertisement -

Logo – https://mma.prnewswire.com/media/2648862/Xojo_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/xojo-2025r2-focuses-on-fundamentals-with-core-improvements-to-increase-developer-productivity-302500439.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

15 minutes ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

15 minutes ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

15 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

16 minutes ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

16 minutes ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

16 minutes ago